Lion Point Capital, LP AVADEL PHARMACEUTICALS PLC Transaction History
Lion Point Capital, LP
- $9.73 Million
- Q1 2025
Number of Shares
98,700
Previous 64,000
54.22%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%